Skip to search.
 TSX Down 0.08% TSX Ventures Up 0.73%

BELLUS Health, Inc. (BLU.TO)

-Toronto
1.25 Up 0.02(1.63%) Feb 5, 3:54PM EST
Prev Close:1.23
Open:1.26
Bid:1.25
Ask:1.26
1y Target Est:N/A
Beta:3.26726
Earnings Date:Feb 23 - Feb 29 (Est.)
Day's Range:1.25 - 1.26
52wk Range:0.76 - 1.44
Volume:40,260
Avg Vol (3m):11,394
Market Cap:68.38M
P/E (ttm):N/A
EPS (ttm):-0.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):19.24
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.04
Quarterly EPS Est (Mar-15) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BELLUS Health Inc., together with its subsidiaries, focuses on the research and development of pharmaceutical drug candidates. The company’s lead program is KIACTA, which is in Phase III clinical trial for the treatment of AA amyloidosis. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback